Bacteria-fighting proteins in sepsis-related lung injury
Part of Infections, Lungs & breathing clinical trials.
This study looks at tiny particles from bacteria and a type of cell death called ferroptosis (iron-related cell breakdown) in patients who have sepsis from an infection outside the lungs. It aims to find signs that could lead to new treatments for lung injury caused by this bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- Your doctor thinks you have sepsis from an infection that started somewhere other than your lungs, like your belly, urine, or skin.
- You had blood or other cultures taken as part of your normal care.
- Your first blood sample for this study is collected within 6 hours of starting sepsis tests.
- You do not have lung injury at the time the study begins.
- You or your family member can give permission (consent) to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the air sacs (alveoli) in your lungs to understand how they are affected by sepsis and a related condition called ARDS. By sampling the fluid in your lungs through a bronchoscopy, researchers hope to find new ways to treat and prevent lung damage.
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
This study tests if transferring healthy gut bacteria (fecal microbiota transplant) can help people with acute lung injury caused by sepsis. It aims to reduce inflammation and improve breathing.
This trial looks at specific cell damage processes (called ferroptosis and pyroptosis) in very sick ICU patients. The goal is to learn more about these processes so doctors can better treat life-threatening organ failure caused by conditions like sepsis, trauma, or severe bleeding.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This study is testing a new tool to predict how well people with pneumonia or sepsis will recover. If you have either infection and are 18 or older, you may be able to join.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.